Literature DB >> 34750225

D2-Like Receptor Expression in the Hippocampus and Amygdala Informs Performance on the Stop-Signal Task in Parkinson's Disease.

Leah G Mann1,2, Kaitlyn R Hay2, Alexander K Song2, Steven P Errington3, Paula Trujillo2, David H Zald3,4, Yan Yan5, Hakmook Kang5, Gordon D Logan3, Daniel O Claassen6.   

Abstract

The stop-signal task is a well-established assessment of response inhibition, and in humans, proficiency is linked to dorsal striatum D2 receptor availability. Parkinson's disease (PD) is characterized by changes to efficiency of response inhibition. Here, we studied 17 PD patients (6 female and 11 male) using the stop-signal paradigm in a single-blinded d-amphetamine (dAMPH) study. Participants completed [18F]fallypride positron emission topography (PET) imaging in both placebo and dAMPH conditions. A voxel-wise analysis of the relationship between binding potential (BPND) and stop-signal reaction time (SSRT) revealed that faster SSRT is associated with greater D2-like BPND in the amygdala and hippocampus (right cluster q FDR-corr = 0.026, left cluster q FDR-corr = 0.002). A region of interest (ROI) examination confirmed this association in both the amygdala (coefficient = -48.26, p = 0.005) and hippocampus (coefficient = -104.94, p = 0.007). As healthy dopaminergic systems in the dorsal striatum appear to regulate response inhibition, we interpret our findings in PD to indicate either nigrostriatal damage unmasking a mesolimbic contribution to response inhibition, or a compensatory adaptation from the limbic and mesial temporal dopamine systems. These novel results expand the conceptualization of action-control networks, whereby limbic and motor loops may be functionally connected.SIGNIFICANCE STATEMENT While Parkinson's disease (PD) is characteristically recognized for its motor symptoms, some patients develop impulsive and compulsive behaviors (ICBs), manifested as repetitive and excessive participation in reward-driven activities, including sex, gambling, shopping, eating, and hobbyism. Such cognitive alterations compel a consideration of response inhibition in PD. To investigate inhibitory control and assess the brain regions that may participate, we assessed PD patients using a single-blinded d-amphetamine (dAMPH) study, with [18F]fallypride positron emission topography (PET) imaging, and stop-signal task performance. We find a negative relationship between D2-like binding in the mesial temporal region and top-signal reaction time (SSRT), with greater BPND associated with a faster SSRT. These discoveries indicate a novel role for mesolimbic dopamine in response inhibition, and advocate for limbic regulation of action control in this clinical population.
Copyright © 2021 the authors.

Entities:  

Keywords:  Parkinson's disease; dopamine; hippocampus; limbic; mesial temporal; response inhibition

Mesh:

Substances:

Year:  2021        PMID: 34750225      PMCID: PMC8638685          DOI: 10.1523/JNEUROSCI.0968-21.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  51 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.

Authors:  Jogeshwar Mukherjee; Bradley T Christian; Kelly A Dunigan; Bingzhi Shi; Tanjore K Narayanan; Martin Satter; Joseph Mantil
Journal:  Synapse       Date:  2002-12-01       Impact factor: 2.562

3.  Think before you leap: donepezil reduces falls?

Authors:  J Eric Ahlskog
Journal:  Neurology       Date:  2010-09-08       Impact factor: 9.910

4.  Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.

Authors:  Kalen Petersen; Nelleke Van Wouwe; Adam Stark; Ya-Chen Lin; Hakmook Kang; Paula Trujillo-Diaz; Robert Kessler; David Zald; Manus J Donahue; Daniel O Claassen
Journal:  Hum Brain Mapp       Date:  2017-10-31       Impact factor: 5.038

5.  Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease.

Authors:  Paula Trujillo; Nelleke C van Wouwe; Ya-Chen Lin; Adam J Stark; Kalen J Petersen; Hakmook Kang; David H Zald; Manus J Donahue; Daniel O Claassen
Journal:  Cortex       Date:  2019-01-29       Impact factor: 4.027

6.  Inattention, impulsive action, and subjective response to D-amphetamine.

Authors:  Jessica Weafer; Harriet de Wit
Journal:  Drug Alcohol Depend       Date:  2013-06-18       Impact factor: 4.492

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Authors:  Nicola J Ray; Janis M Miyasaki; Mateusz Zurowski; Ji Hyun Ko; Sang Soo Cho; Giovanna Pellecchia; Francesca Antonelli; Sylvain Houle; Anthony E Lang; Antonio P Strafella
Journal:  Neurobiol Dis       Date:  2012-07-03       Impact factor: 5.996

9.  Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.

Authors:  T Pohjalainen; J O Rinne; K Någren; E Syvälahti; J Hietala
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

10.  Release the BEESTS: Bayesian Estimation of Ex-Gaussian STop-Signal reaction time distributions.

Authors:  Dora Matzke; Jonathon Love; Thomas V Wiecki; Scott D Brown; Gordon D Logan; Eric-Jan Wagenmakers
Journal:  Front Psychol       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.